Book chapter · 2011 · Open access
Alpha-Synuclein and the Immune Response in Parkinson’s Disease
InTech eBooks · Published 2 November 2011 · DOI 10.5772/17417
In brief
“Alpha-Synuclein and the Immune Response in Parkinson’s Disease” is a 2011 book chapter by Cintia Roodveldt and 3 co-authors, published in InTech eBooks. OpenAlex counts 5 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at InTech eBooks.
- Citations
- 5
- Most cited in
- 2013 (2)
- Field-weighted impact
- 2.09
- References
- 160
- Authors
- 4
Abstract
In the last few years, it has become evident that the immunological component is of central\nimportance in Parkinson’s Disease (PD) pathogenesis and progression. This can also\ncertainly be said about the prominent role that the protein -synuclein (Syn) is currently\nbelieved to play in the pathobiology of this neurodegenerative disorder. Moreover, the\nmultiple mechanisms through which Syn might be affecting the immune system appear\nnot to be just a consequence of disease progression, but to actively contribute to the delicate\nbalance between neuroprotection and neurotoxicity that ultimately underlies a given stage\nof disease.\nPD is a proteinopathy, whose pathological hallmark is the presence of deposits of\naggregated Syn in intracellular fibrillar inclusions in neurons of the substantia nigra pars\ncompacta (SN) of the brain, known as Lewy bodies (LB) (Croisier et al., 2005; Spillantini et al.,\n1998), and the loss of dopaminergic neurons (Braak et al., 2003). Three missense mutations,\nA53T, A30P and E46K, as well as multiple copies of the wild-type (Wt) Syn gene, are\nlinked to early-onset, familial PD (Gasser, 2005; Kruger et al., 1998; Polymeropoulos et al.,\n1997; Zarranz et al., 2004). Given that Syn is the major component of LB in both familial\nand sporadic PD cases (Spillantini et al., 1998), Syn is considered a critical factor in PD\naetiology. Currently, the cellular and molecular mechanisms underlying the pathological\nactions of Syn are poorly understood, and the factors contributing to sporadic PD,\nrepresenting the vast majority of PD cases, are not known.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Roodveldt, C., Labrador‐Garrido, A., Izquierdo, G., & Pozo, D. (2011). Alpha-Synuclein and the Immune Response in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/17417
MLA 9
Roodveldt, Cintia, et al. “Alpha-Synuclein and the Immune Response in Parkinson’s Disease.” InTech eBooks, 2011. https://doi.org/10.5772/17417.
Chicago
Roodveldt, Cintia, Adahir Labrador‐Garrido, Guillermo Izquierdo, and David Pozo. 2011. “Alpha-Synuclein and the Immune Response in Parkinson’s Disease.” InTech eBooks. https://doi.org/10.5772/17417.
Harvard
Roodveldt, C. et al. (2011) ‘Alpha-Synuclein and the Immune Response in Parkinson’s Disease’, InTech eBooks. doi:10.5772/17417.
IEEE
C. Roodveldt, A. Labrador‐Garrido, G. Izquierdo, and D. Pozo, “Alpha-Synuclein and the Immune Response in Parkinson’s Disease,” InTech eBooks, 2011, doi: 10.5772/17417.
BibTeX
@incollection{roodveldt2011alpha,
title = {{Alpha-Synuclein and the Immune Response in Parkinson’s Disease}},
author = {Roodveldt, Cintia and Labrador‐Garrido, Adahir and Izquierdo, Guillermo and Pozo, David},
booktitle = {InTech eBooks},
year = {2011},
doi = {10.5772/17417},
url = {https://doi.org/10.5772/17417}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 2 | |
| 2017 | 2 | |
| 2020 | 1 |
Its field-weighted citation impact is 2.09: it has been cited 2.09 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- alpha-synuclein
- Parkinson's disease
- immune response
- neuroinflammation
- Lewy bodies
- protein aggregation
- dopaminergic neuron loss
- substantia nigra
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Roodveldt, C., Labrador‐Garrido, A., Izquierdo, G., & Pozo, D. (2011). Alpha-Synuclein and the Immune Response in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/17417
How many times has this paper been cited?
5 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at InTech eBooks: sign in and open the PDF from this page.
Who wrote this paper?
Cintia Roodveldt, Adahir Labrador‐Garrido, Guillermo Izquierdo, David Pozo.
What is the DOI of this paper?
10.5772/17417, permanently at https://doi.org/10.5772/17417. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.